SLG
31
3
GILD
63
-4
CB
31
-2
BIIB
40
-2
DVA
59
-13
NAVI
47
6
KR
55
-2
SE
82
3
PCAR
43
3
VRSK
61
-2
INTC
47
4
DRI
63
-3
BXP
28
-13
MCHP
51
6
ALL
50
-7
CL
50
-8
FRT
51
-12
PX
52
2
PSX
42
5
XRX
34
2
SLG
31
3
GILD
63
-4
CB
31
-2
BIIB
40
-2
DVA
59
-13
NAVI
47
6
KR
55
-2
SE
82
3
PCAR
43
3
VRSK
61
-2
INTC
47
4
DRI
63
-3
BXP
28
-13
MCHP
51
6
ALL
50
-7
CL
50
-8
FRT
51
-12
PX
52
2
PSX
42
5
XRX
34
2
Financhill
Back

Kura Oncology Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
35

KURA
Kura Oncology

Last Price:
$8.09
Seasonality Move:
0.11%
Sell
41

SRPT
Sarepta Therapeutics

Last Price:
$105.00
Seasonality Move:
1.75%
Sell
35
Kura Oncology (KURA) is a Sell

Is Kura Oncology a Buy, Sell or Hold?

  • The current Kura Oncology [KURA] share price is $8.28. The Score for KURA is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • KURA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $107.95. The Score for SRPT is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

KURA Stock Price Chart

What is Kura Oncology's stock price today?

  • The Kura Oncology share price today is $8.28
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KURA is experiencing selling pressure, which indicates risk of future bearish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $107.95
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

KURA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.08 Sell
Relative Strength Index (14 RSI): 46.2 Sell
Chaikin Money Flow: -535200 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.43 - 8.57) Buy
Bollinger Bands (100): (8.23 - 17.45) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.94 Sell
Relative Strength Index (14 RSI): 33.84 Sell
Chaikin Money Flow: -502758 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.52 - 119.16) Sell
Bollinger Bands (100): (114.38 - 127.78) Sell

KURA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 8.57 Sell
20-day SMA: 8.19 Buy
50-day SMA: 8.7 Sell
200-day SMA: 16.74 Sell
8-day EMA: 8.4 Sell
20-day EMA: 8.36 Sell
50-day EMA: 9.47 Sell
200-day EMA: 14.26 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 111.57 Sell
20-day SMA: 114.25 Sell
50-day SMA: 119.8 Sell
200-day SMA: 128.55 Sell
8-day EMA: 110.88 Sell
20-day EMA: 113.91 Sell
50-day EMA: 117.81 Sell
200-day EMA: 123.39 Sell

Kura Oncology Earnings Growth & KURA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.51 per share, and a decrease next year of $0.04 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.70 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.63 per share, and an increase next year of $4.84 per share.

Kura Oncology Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):